Sustaining Improvements in Colorectal Cancer Across Delaware:: A Look at Racial Disparities a Decade Later.

A previously initiated statewide effort in Delaware improved outcomes in colorectal cancer (CRC) racial disparities. To examine whether improvements in racial disparities for CRC have been sustained a decade later and the status of Delaware's current cancer burden. Cancer incidence data from the Delaware Cancer Registry, mortality data from the Centers for Disease and Control and Prevention (CDC)'s National Center for Health Statistics, and cancer screening data from CDC's Behavioral Risk Factor Surveillance System were analyzed.

Timeliness of Breast Cancer Treatment in Delaware.

Studies have shown timely screening, diagnosis, and treatment of breast cancer reduces mortality rates. The objective of this study is to evaluate the overall timeliness of breast cancer diagnosis and treatment for Delawarean women using the Centers for Disease Control and Prevention's (CDC) National Breast and Cervical Cancer Early Detection Program's (NBCCEDP) recommendations of 60 days maximum for screening to diagnosis and 60 days maximum for diagnosis to treatment. This study analyzed Delaware Cancer Registry (DCR) data for female Delawarean breast cancer patients diagnosed in 2010 who had valid screening, diagnosis, and treatment dates.

Public Health Response to Diabetes in Delaware through Partnership, Referral, and the Diabetes Self-Management Program.

Diabetes is a major health concern in Delaware, affecting approximately 85,000 adult Delawareans. Diabetes can lead to amputation, blindness, kidney failure, impaired hearing, heart and dental disease, and other complications. The Division of Public Health (DPH) launched a project in collaboration with Quality Insights (QI) to assist physician practices improve their National Quality Forum (NQF) Clinical Quality Measure NQF 0059.

Timeliness of Breast Cancer Treatment in Delaware.

Studies have shown timely screening, diagnosis, and treatment of breast cancer reduces mortality rates. The objective of this study was to evaluate the overall timeliness of breast cancer diagnosis and treatment for Delawarean women using the Centers for Disease Control and Prevention (CDC)'s National Breast and Cervical Cancer Early Detection Program (NBCCEDP)'s recommendations of 60 days maximum for screening to diagnosis and 60 days maximum for diagnosis to treatment. This study analyzed Delaware Cancer Registry data for female Delawarean breast cancer patients diagnosed in 2010 who had valid screening, diagnosis, and treatment dates.